better choice company inc. operates as an animal health and wellness company. it offers raw-diet dog food and treats, naturally formulated premium kibble and canned dog and cat food, hemp-based cbd soft chews and flavor-infused tinctures, oral care products, supplements, and grooming aids. the company provides its products for dogs, cats, and pet parents under the halo, trudog, trugold, rawgo!, and orapup brand names. better choice company inc. primarily sells its products through its online portal, as well as through online retailers and pet specialty stores. it has operations in the united states, canada, and asia. the company was founded in 2013 and is headquartered in oldsmar, florida.
Company profile
Ticker
BTTR
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Sport Endurance, Inc.
SEC CIK
Corporate docs
Subsidiaries
Bona Vida, Inc. • Halo, Purely for Pets, Inc. • Wamore Corporation S.A. ...
IRS number
262754069
BTTR stock data
Latest filings (excl ownership)
8-K
Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results
17 Apr 24
8-K
Other Events
16 Apr 24
10-K
2023 FY
Annual report
12 Apr 24
8-K
Departure of Directors or Certain Officers
4 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
Material Modifications to Rights of Security Holders
25 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
14 Mar 24
DEF 14C
Information statement
27 Feb 24
PRE 14C
Preliminary information
16 Feb 24
8-K
Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market
12 Feb 24
Transcripts
BTTR
Earnings call transcript
2022 Q3
10 Nov 22
BTTR
Earnings call transcript
2022 Q2
14 Aug 22
BTTR
Earnings call transcript
2022 Q1
15 May 22
BTTR
Earnings call transcript
2022 Q1
12 May 22
BTTR
Earnings call transcript
2021 Q4
29 Mar 22
BTTR
Earnings call transcript
2021 Q3
14 Nov 21
BTTR
Earnings call transcript
2021 Q3
10 Nov 21
BTTR
Earnings call transcript
2021 Q2
14 Aug 21
BTTR
Earnings call transcript
2021 Q2
12 Aug 21
BTTR
Earnings call transcript
2021 Q1
15 May 21
Latest ownership filings
SC 13G/A
HEP Partners LLC
14 Feb 24
4
Gil Fronzaglia
5 Feb 24
4
John M Word III
5 Feb 24
4
Lionel F. Conacher
5 Feb 24
4
Michael Young
5 Feb 24
4
Arlene Dickinson
5 Feb 24
4
Lionel F. Conacher
7 Sep 23
4
Michael Young
7 Sep 23
SC 13G/A
Word John M III
14 Feb 23
SC 13G/A
Brown Edward James Jr.
14 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.80 mm | 3.80 mm | 3.80 mm | 3.80 mm | 3.80 mm | 3.80 mm |
Cash burn (monthly) | (no burn) | 734.58 k | 872.00 k | 2.79 mm | (no burn) | 289.58 k |
Cash used (since last report) | n/a | 4.99 mm | 5.93 mm | 18.95 mm | n/a | 1.97 mm |
Cash remaining | n/a | -1.19 mm | -2.13 mm | -15.15 mm | n/a | 1.83 mm |
Runway (months of cash) | n/a | -1.6 | -2.4 | -5.4 | n/a | 6.3 |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 28 |
Opened positions | 6 |
Closed positions | 2 |
Increased positions | 6 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 389.13 mm |
Total shares | 7.98 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
HEP Partners | 2.51 mm | $0.00 |
Must Asset Management | 1.41 mm | $168.89 mm |
Cavalry Fund I | 1.29 mm | $0.00 |
Perkins Capital Management | 782.83 k | $97.00 k |
Vanguard | 457.23 k | $56.70 mm |
Callan Capital | 243.31 k | $30.17 mm |
Vanguard Capital Wealth Advisors | 236.84 k | $29.37 mm |
Brown Brothers Harriman & Co | 227.24 k | $28.18 mm |
Geode Capital Management | 146.65 k | $18.18 mm |
Renaissance Technologies | 105.40 k | $13.00 k |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Jan 23 | Lionel F. Conacher | Common Stock | Grant | Acquire A | No | No | 0 | 18,021 | 0.00 | 315,817 |
11 Jan 23 | Robert Sauermann | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 68,800 |
11 Jan 23 | Sharla A Cook | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 46,502 |
11 Jan 23 | Donald Young | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 590,601 |
4 Jan 23 | Gil Fronzaglia | Common Stock | Grant | Acquire A | No | No | 0.56 | 178,572 | 100.00 k | 227,241 |
News
Why Better Choice Stock Is Climbing Higher Today
16 Apr 24
Better Choice Company Initiates Legal Action Against Alphia For Monetary Damages In Excess Of $19M
26 Mar 24
Better Choice To Explore Non-Equity Related Capital Solutions To Fund The R&D Of Its Domestic Animal Targeted GLP1 Supplement To Combat Obesity In Dogs And Cats
4 Mar 24
Why Amtech Systems Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
12 Feb 24
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
9 Feb 24
Press releases
Better Choice Company Board of Directors Authorize Stock Repurchase Program
16 Apr 24
Better Choice Company, Inc. Announces Fourth Quarter and Full Year 2023 Results
12 Apr 24
Better Choice Company Initiates Legal Action Against Alphia, a Portfolio Company of Private Equity Firm PAI
26 Mar 24
Better Choice Company To Effectuate a Reverse Stock Split
8 Mar 24
Better Choice to Explore Non-Equity Related Capital Solutions to Fund the R&D of its Domestic Animal Targeted GLP1 Supplement
4 Mar 24